[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100302436":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":42,"centralContacts":47,"locations":56,"responsibleParty":74,"collaborators":23,"id":78,"slug":23,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":23,"eligibilityCriteria":83,"healthyVolunteers":84,"sex":85,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":23,"studyType":91,"phases":92,"briefSummary":94,"conditions":95,"keywords":101,"overallStatus":58,"whyStopped":23,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"University of Iowa","OTHER",[8,14,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"patient active rTMS","EXPERIMENTAL","Subjects will receive 5 days of 2x daily rTMS targeted over the cerebellum.",[13],"Device: Repetitive Transcranial Magnetic Stimulation (rTMS)",{"label":15,"type":16,"description":17,"interventionNames":18},"patient sham rTMS","SHAM_COMPARATOR","Subjects will receive 5 days of 2x daily sham stimulation of the cerebellum.",[19],"Device: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)",{"label":21,"type":22,"description":23,"interventionNames":24},"Control active rTMS","ACTIVE_COMPARATOR",null,[13],{"label":26,"type":16,"description":23,"interventionNames":27},"Control sham rTMS",[19],[29,36],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DEVICE","Repetitive Transcranial Magnetic Stimulation (rTMS)","Subjects with neuropsychiatric diagnoses and matched-controls will be receive theta frequency stimulation of the cerebellum. We will target the cerebellar vermis.",[21,9],[35],"rTMS",{"type":30,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"Sham Repetitive Transcranial Magnetic Stimulation (rTMS)","Subjects with neuropsychiatric diagnoses and matched-controls will be receive sham stimulation of the cerebellum. We will target the cerebellar vermis.",[26,15],[41],"Sham stimulation",[43],{"name":44,"affiliation":45,"role":46},"Krystal L Parker, Ph.D","Univeristy of Iowa","PRINCIPAL_INVESTIGATOR",[48,52],{"name":44,"role":49,"phone":50,"phoneExt":23,"email":51},"CONTACT","319-353-4554","CT201610712@gmail.com",{"name":53,"role":49,"phone":54,"phoneExt":23,"email":55},"Benjamin Pace, M.S.","319-384-9302","benjamin-pace@uiowa.edu",[57],{"facility":5,"status":58,"city":59,"state":60,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"RECRUITING","Iowa City","Iowa","52245","United States","US",{"type":65,"coordinates":66},"Point",[67,68],-91.53017,41.66113,{"lat":68,"lon":67},[71],{"name":44,"role":49,"phone":72,"phoneExt":23,"email":73},"319-353-3554","krystal-parker@uiowa.edu",{"type":75,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"SPONSOR_INVESTIGATOR","Krystal Parker, PhD","Assistant Professor","100302436",false,"NCT03217110","Cerebellar Stimulation and Cognitive Control","Cerebellar Transcranial Magnetic Stimulation and Cognitive Control","Inclusion Criteria:\n\n* A clinical diagnosis consistent with enrollment\n\nExclusion Criteria:\n\n* History of recurrent seizures or epilepsy\n* Any other neurological or psychiatric diagnosis outside the diagnosis for which the participant is enrolled.\n* Active substance use disorder in the past 6 months other than tobacco use disorder.\n* Inability to consent for study.\n* Pacemaker\n* Coronary Stent\n* Defibrillator\n* Neurostimulation\n* Claustrophobia\n* Uncontrolled high blood pressure\n* Atrial fibrillation\n* Significant heart disease\n* Hemodynamic instability\n* Kidney disease\n* Pregnant, trying to become pregnant, or breast feeding",true,"ALL","18 Years","90 Years",{"count":89,"type":90},200,"ESTIMATED","INTERVENTIONAL",[93],"NA","The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.",[96,97,98,99,100],"Schizophrenia","Autism Spectrum Disorder","Bipolar Disorder","Depression","Parkinson Disease",[102],"Cerebellum","2026-03-16",{"date":105,"type":106},"2026-03-19","ACTUAL",{"date":108,"type":106},"2017-11-30",{"date":110,"type":90},"2028-12-01",{"name":76,"class":6},1]